INTRODUCTION
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with abdominal pain, discomfort, and changes in bowel habit. Its prevalence ranges in population-based studies between 10 and 26% in western countries. 1 In a recent review of IBS in EU countries the prevalence was approximated as 10% of the adult population with an average cost of 1000 per patient year, leading to a total cost of 28.38 billion. 2 The definition of IBS has changed over time. In 1978, Manning published the first symptom-based diagnostic criteria for IBS, which since then have been widely used in epidemiological studies. According to Manning criteria, the more of the following six symptoms are present, the more likely the IBS diagnosis: looser stools at onset of pain, more frequent bowel movements at onset of pain, pain eased after bowel movement, abdominal distension, passage of mucus, or feeling of incomplete evacuation. 3 No minimum number of these six symptoms was recommended, however, resulting in the use of various number of symptoms, usually two or three, to define IBS. [4] [5] [6] [7] In 1989, a working committee published new criteria for IBS diagnosis, 8 criteria then revised and published in 1992 as the Rome criteria (later Rome I criteria). 9 The newest definition and diagnostic criteria for IBS, the Rome II criteria, appeared in 1999. 10 Our objectives were to assess the effect of diagnostic criteria on prevalence figures for IBS in a populationbased setting and to evaluate whether the IBS groups detected differed in respect to demographic properties, severity of IBS symptoms, use of health care facilities, depression and anxiety. Finnish version (RBDI) has been developed for population-screening purposes. 14 A positive-choice answer has been added to each item to measure self-confidence. The Finnish modification contains 14-items: 13 for depression and one for anxiety and it has shown good reliability and validity in screening the Finnish population. 15 Depression is defined as mild at a score of 5-7, moderate, [8] [9] [10] [11] [12] [13] [14] [15] , and severe at 16 or more. Anxiety is defined as mild (score 1), moderate (score 2) or severe (score 3). The questionnaire also covered basic demographic data, previous gastrointestinal diseases and symptoms, operations, medications, severity of IBS-symptoms if present, and factors worsening the symptoms. Abdominal pain and discomfort was assessed by a 4-grade Likert scale (mild, moderate, severe, very severe). Frequency of abdominal pain/discomfort was assessed by 5-grades (seldom or never, sometimes, often, very often, constantly).
MATERIALS AND METHODS
All questionnaires returned were scanned optically, and data was transformed into Excel-form for analysis.
STATISTICAL METHODS
Data were analysed with spss and ncss software. Prevalence figures according to each diagnostic criteria were calculated with 95% confidence intervals (CI). Two variables were considered statistically different if their 95% CI did not overlap. Variables were analysed for associations with each diagnostic category by the chi-square test for categorical and t-test for dimensional variables. Concordance between the criteria was analysed with j statistics. A j-value of 0.0-0.2 indicates slight agreement, 0.2-0.4 fair agreement, 0.4-0.6 moderate agreement, and 0.6-0.8 substantial agreement; a j-value of 0.8-1.0 indicates near perfect agreement. 16 
RESULTS
The random sample included 5000 subjects. The postal service reported 22 unknown addresses and returned those letters. After two reminders, the response rate was 73.0%, higher among females (78.9%) than males (67.0%). Mean age of respondents was 42.1 years (95% CI: 41.6-42.5) with the male-to-female ratio of 45.1/ 54.9%. Non-respondents were younger than respondents, with a mean age of 38.7 years (95% CI: 37.3-39.0). The oldest age group (55-65 years) showed no statistically significant difference in response rate by gender. In all the other age groups, females were more likely to respond than males ( Table 2) .
Prevalence of IBS
Altogether 600 respondents (16.5%) fulfilled at least one of the IBS criteria. The prevalence of IBS according to Manning 2, Manning 3, Rome I, and Rome II criteria was 16.2%, 9.7%, 5.6%, and 5.1%, respectively. IBS was more common among females based on either of the Manning criteria, while Rome I and Rome II criteria revealed no differences in gender distribution. No statistically significant differences appeared between prevalences of IBS among age groups for any of the criteria applied (Table 3) .
Overlap among diagnostic criteria is shown in Figure 1 . Of the 600 subjects meeting any IBS criteria, 587 (97.8%) also met Manning 2 criteria. One hundred and seventy-nine subjects (97.3%) of the Rome II group also met Manning 2 criteria, and 153 (83.2%) of the Rome II group also met Rome I criteria. Only four subjects (2.2%) in the Rome II group met no IBS definition other than Rome II. Both Manning 2 and Manning 3 criteria showed a moderate agreement with Rome II, with j-values of 0.42 and 0.52, respectively. Their agreement with Rome I criteria was slightly better, with respective j-values of 0.45 and 0.53. However, Rome I and Rome II criteria showed a substantial agreement, with a j-value of 0.78.
Demographics
No significant difference existed in age distribution or marital status between those meeting an IBS criterion and controls. The lowest educational level was less frequent among respondents fulfilling either of the Manning criteria. On the contrary, Rome I-and Rome II-positive groups showed a tendency towards a lower percentage at the highest educational level (high-school graduate). Those who met three Manning-symptom criteria more frequently worked irregular hours than did those not meeting Manning 3 criteria. Among Manning 2, Rome I or Rome II groups, there appeared a tendency towards over-representation of irregular working hours, although this failed to reach statistical significance (Table 4) . 
Symptoms
The diarrhoea-predominant form of IBS was more common than the constipation predominant, regardless of criteria. Of IBS-positive respondents, diarrhoea predominance ranged from 41 to 57%. Prevalence of diarrhoea among the total sample was 14.3%. Constipation occurred in 15.1% of all respondents. Constipation-predominant IBS was commonest among those fulfilling Rome I criteria (26.5%), but in the Rome II group constipation prevalence did not differ from that of the total sample (Table 4) . Of subjects meeting Rome I or Rome II criteria, 44% reported severe or very severe abdominal pain, and the comparable proportion of those meeting Manning 2 or Manning 3 criteria was 27 and 30%. Daily activities among both Rome groups were also more frequently disturbed because of the abdominal symptoms (Figure 2a,b) . These findings were significant at 95% CI.
Of the total sample, 602 subjects (17.2%, 95% CI: 15.9-18.5) suffered from depression according to the RBDI (depression score 5 or more). The prevalence of depression was 30.6% (95% CI: 26.9-34.3) in Manning 2 group, 35.1% (95% CI: 30.0-40.1) in Manning 3, 42.9% (95% CI: 35.9-49.8) in Rome I, and 39.3% (95% CI: 32.1-46.5) in Rome II group. Depression was most frequent among those meeting any IBS criteria, and significantly more common in the Rome I group than in the Manning 2 group. Among the 602 subjects experiencing depression, prevalence of IBS according to Rome II was 11.7% for both sexes.
Anxiety was also almost twice as common among subjects meeting any IBS criteria than among controls but with no significant differences among any IBS diagnostic criteria (Table 4) .
Use of health care resources
As expected, a greater proportion of those suffering from IBS, regardless of criterion, had visited a doctor for abdominal complaints at least once during the previous year than had controls. When we compared different IBS criteria we found that visiting a doctor was more common among Rome I and Rome II groups than among either Manning group (Figure 3) . Visiting a doctor at least once for reasons other than abdominal complaints was also more frequent among subjects meeting any IBS criteria. No significant differences appeared between diagnostic criteria concerning this variable.
DISCUSSION
The Rome II Integrative Questionnaire, a new tool for epidemiological studies, was published in 2000, modified from an earlier version. 17 To our knowledge, the literature at the moment offers no other studies applying the same instrument. Translation of the English questionnaire into Finnish may be a source of bias as some expressions can have different meanings in different languages and cultures. However, back translation of the questionnaire into English did not reveal differences in the content of the items suggesting that translation into Finnish would not affect the number of IBS-positive subjects detected by the questionnaire. In our study, evaluation of a large random sample with a good overall response rate of 73% lends support to the reliability of the findings. The prevalence of IBS, according to Manning 2, Manning 3, Rome I, and Rome II criteria shows substantial variation, depending on diagnostic criteria applied. In several epidemiological studies, IBS diagnosis has been based on fulfilment of two of the six Manning symptoms. In our study, this criterion will produce about threefold greater prevalence figures than will Rome II criteria, which has been recommended for use both in clinical studies and practice. This is in accordance with previously reported results from populationbased studies. 5, 6, 18 In our study, subjects fulfilling either of the Rome criteria had more severe abdominal symptoms than did those with two or three Manning symptoms. Of the six Manning symptoms, only three are associated with pain, while the others ('visible abdominal distension', 'passage of mucus', 'feeling of incomplete evacuation') are not pain-related, which may explain the differences in the severity of abdominal pain among Rome and Manning groups. In a previous study, those fulfilling Rome criteria have more severe abdominal symptoms and demonstrate higher levels of psychopathology such as depression, anxiety, and somatization than do those detected by Manning criteria, which is in accordance with our results. 5 A larger proportion of our Romepositive subjects had also consulted a doctor during the previous year for abdominal complaints. That a larger proportion of subjects who met any IBS criteria had also visited a doctor for reasons other than abdominal complaints may be due to an over-representation in IBS of depression and anxiety or possibly some other comorbidity. The prevalence of depression and anxiety is higher among IBS sufferers than in the general population and depression seems even more frequent among those meeting either of the Rome criteria than those meeting Manning 2 criteria. Detection and adequate treatment of underlying depression may benefit the patient more than concentrating only on abdominal symptoms. From the clinician's viewpoint, it is important to have diagnostic criteria applicable to clinical work. Rome II criteria seem reasonably handy for the clinician, because they are sufficiently short and simple to be useful in a busy practice. On the contrary, they leave the doctor the choice of how to ask the patient about symptom history. It may be possible to lead the interview in such a way that the doctor will obtain the required answers for the patient to fulfil Rome II criteria, although another clinician would disagree on such a diagnosis based on the same criteria. A clinician would probably base the diagnosis of IBS on a conversation with the patient and an impression of the patient's symptoms as a whole rather than on using a standardized questionnaire providing more standardized answers. Another important issue is the reliability of the criteria for clinical work. The positive predictive value of Rome I criteria has been reported to be as high as 100% in a retrospective study, 20 but the specificity and sensitivity of Rome II criteria remains unknown. New drugs are being developed for IBS, with the patients in the latest clinical drug trials selected based on Rome II criteria. It is important that clinicians be able to detect IBS by the same criteria, because the efficacy and safety of new drugs has been shown only in this patient population, which seems to differ from those fulfilling the older IBS definition. Otherwise, data from large drug studies is not readily applicable to all patients treated by general practitioners. On the contrary, it is possible that the indications for new IBS drugs will be broadened, for example, for functional constipation and functional diarrhoea, which could lessen this problem.
In conclusion, IBS is not as common an abdominal disorder by Rome II criteria as by Manning criteria. Rome II-positive IBS subjects seem to form a subgroup of Manning-positive subjects with higher levels of abdominal pain, more symptom-caused disturbance of daily activities, more mental symptoms, and more use of the health care system.
